Emerald Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 10
Rang # Quantité totale PI 154 956
Note d'activité PI 1,3/5.0    4
Rang # Activité PI 240 891
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

4 1
0 0
4 1
0
 
Dernier brevet 2024 - Rotationally sequestered transla...
Premier brevet 2011 - System and method for propagatin...
Dernière marque 2021 - EMERALD THERAPEUTICS
Première marque 2015 - EMERALD THERAPEUTICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Rotationally sequestered translators. Provided are nucleic acid translators capable of carrying ...
2023 Invention Preparation of oligo conjugates. Conjugated molecules are prepared that comprise a predetermined...
2021 P/S Pharmaceutical preparations used to treat viral infections; pharmaceutical preparations, namely, ...
2020 Invention Rotationally sequestered translators. Provided are nucleic acid translators capable of carrying o...
Invention System and method for propagating information using modified nucleic acids. A method is provided...
2019 Invention Polynucleotide probe design. An approach to designing a polynucleotide probe to hybridize select...
2015 P/S Pharmaceutical preparations used to treat viral infections; pharmaceutical preparations, namely,...
2014 Invention Preparation of oligo conjugates. Conjugated molecules are prepared that comprise a predetermined ...
2013 Invention Polynucleotide probe design. An approach to designing a polynucleotide probe to hybridize selecti...
2011 Invention System and method for propagating information using modified nucleic acids. A method for improvin...